{
  "metadata": {
    "file_name": "Health and wellness guide example.pdf",
    "file_path": "c:\\hackathon\\Gemini_CLI\\PEPSI\\data\\Health and wellness guide example.pdf",
    "total_pages": 14,
    "extraction_mode": "detailed"
  },
  "pages": {
    "page_1": {
      "page_number": 1,
      "structured_content": [
        {
          "subheading": "04 de diciembre, 2025"
        },
        {
          "heading": "HEALTH AND WELLNESS GUIDE",
          "subsections": [
            {
              "subheading": "Your path to a longer, healthier life."
            },
            {
              "subheading": "Name:",
              "content": [
                "RICHARD ALLEN PEACOCK"
              ]
            },
            {
              "subheading": "Identification number",
              "content": [
                "AC737267"
              ]
            },
            {
              "subheading": "Date of birth",
              "content": [
                "11/07/1960"
              ]
            },
            {
              "subheading": "Section 1: My Purpose"
            },
            {
              "subheading": "Why do I want to improve my health?",
              "content": [
                "Me and my wife like to do hiking and enjoy outdoors and also I want to be healthy to be with my grandkids and kids."
              ]
            },
            {
              "subheading": "\"We all have a reason that motivates us to take care of ourselves."
            },
            {
              "subheading": "Come back to this section whenever you need to reconnect with your path.\""
            },
            {
              "subheading": "MY PRIMARY HEALTH GOALS",
              "content": [
                "Based on your goals, lifestyle, and health assessment,",
                "we will prioritize three objectives to bring you closer to your purpose."
              ]
            },
            {
              "subheading": "Health Goals"
            },
            {
              "subheading": "Why is this important?"
            },
            {
              "subheading": "1",
              "content": [
                "Improve liver health by reducing inflammation and",
                "normalizing liver enzymes.",
                "to protect the liver, improves metabolism, reduces",
                "cardiovascular risk, and restores whole-body health."
              ]
            },
            {
              "subheading": "2",
              "content": [
                "Improve Insulin Sensitivity and Metabolic Flexibility",
                "to prevent progression to type 2 diabetes"
              ]
            },
            {
              "subheading": "3",
              "content": [
                "Improve lipid balance and reduce long-term",
                "cardiovascular risk.",
                "to prevent progression of atherosclerosis."
              ]
            }
          ]
        }
      ],
      "raw_lines": [
        "04 de diciembre, 2025",
        "HEALTH AND WELLNESS GUIDE",
        "Your path to a longer, healthier life.",
        "Name:",
        "Identification number",
        "Date of birth",
        "RICHARD ALLEN PEACOCK ",
        "AC737267",
        "11/07/1960",
        "Section 1: My Purpose",
        "Why do I want to improve my health?",
        "Me and my wife like to do hiking and enjoy outdoors and also I want to be healthy to be with my grandkids and kids.",
        "\"We all have a reason that motivates us to take care of ourselves.",
        "Come back to this section whenever you need to reconnect with your path.\"",
        "MY PRIMARY HEALTH GOALS",
        "Based on your goals, lifestyle, and health assessment,",
        "we will prioritize three objectives to bring you closer to your purpose.",
        "Health Goals",
        "Why is this important?",
        "1",
        "Improve liver health by reducing inflammation and ",
        "normalizing liver enzymes.",
        "to protect the liver, improves metabolism, reduces ",
        "cardiovascular risk, and restores whole-body health.",
        "2",
        "Improve Insulin Sensitivity and Metabolic Flexibility",
        "to prevent progression to type 2 diabetes",
        "3",
        "Improve lipid balance and reduce long-term ",
        "cardiovascular risk.",
        "to prevent progression of atherosclerosis."
      ]
    },
    "page_2": {
      "page_number": 2,
      "structured_content": [
        {
          "subheading": "Section 2: Results and Findings"
        },
        {
          "subheading": "2.1. SUMMARY:"
        },
        {
          "subheading": "HEALTH AND WELLNESS INTEGRAL EVALUATION",
          "content": [
            "OVERALL INTEGRATED CLINICAL SUMMARY",
            "Richard shows:",
            "Normal findings in:",
            "CBC",
            "Renal function",
            "Thyroid",
            "PSA",
            "Electrolytes",
            "Glucose metabolism",
            "Urinalysis & stool exam",
            "Lp(a) (excellent)",
            "Inflammatory markers only mildly elevated",
            "-Abnormal findings centered around:",
            "NAFLD grade II → Elevated AST/ALT, ferritin, low HDL, elevated LDL, mild insulin resistance",
            "Vitamin D excess → 81.8 ng/mL",
            "ApoB slightly elevated",
            "hs-CRP mildly elevated",
            "-Cardiovascular risk remains LOW because:",
            "CAC score = 15",
            "Lp(a) extremely low",
            "ApoB moderate",
            "HDL low due to fatty liver, not arterial disease",
            "High muscularity and high physical activity"
          ]
        },
        {
          "subheading": "2.2. FUNCTIONAL MEDICINE APPROACH:"
        },
        {
          "subheading": "MODIFIABLE LIFESTYLES AND DYSFUNCTIONS",
          "content": [
            "Functional Medicine Focus — Priority Areas",
            "Reverse NAFLD (primary goal)",
            "Improve liver detox phases, mitochondrial fat oxidation, hepatic glucose handling.",
            "Improve hepatic insulin sensitivity",
            "Adjust macronutrient timing; increase fiber and plants; adjust fructose load.",
            "Lower inflammation",
            "Through nutrition, circadian alignment, and omega-3.",
            "Support mitochondrial function",
            "Maintain exercise, optimize micronutrients (magnesium, B-complex).",
            "Normalize Vitamin D",
            "Reduce dose.",
            "Improve evening metabolic activity",
            "Introduce low-intensity movement after 3–4 pm.",
            "Dermatologic follow-up",
            "Actinic keratosis & ulcerated lesion require evaluation."
          ]
        },
        {
          "subheading": "2.3. VITAL SIGNS AND BODY COMPOSITION ANALYSIS (INBODY)"
        }
      ],
      "raw_lines": [
        "Section 2: Results and Findings",
        "HEALTH AND WELLNESS INTEGRAL EVALUATION",
        "OVERALL INTEGRATED CLINICAL SUMMARY",
        "Richard shows:",
        "Normal findings in:",
        "CBC",
        "Renal function",
        "Thyroid",
        "PSA",
        "Electrolytes",
        "Glucose metabolism",
        "Urinalysis & stool exam",
        "Lp(a) (excellent)",
        "Inflammatory markers only mildly elevated",
        "-Abnormal findings centered around:",
        "NAFLD grade II → Elevated AST/ALT, ferritin, low HDL, elevated LDL, mild insulin resistance",
        "Vitamin D excess → 81.8 ng/mL",
        "ApoB slightly elevated",
        "hs-CRP mildly elevated",
        "-Cardiovascular risk remains LOW because:",
        "CAC score = 15",
        "Lp(a) extremely low",
        "ApoB moderate",
        "HDL low due to fatty liver, not arterial disease",
        "High muscularity and high physical activity",
        "Functional Medicine Focus — Priority Areas",
        "Reverse NAFLD (primary goal)",
        "Improve liver detox phases, mitochondrial fat oxidation, hepatic glucose handling.",
        "Improve hepatic insulin sensitivity",
        "Adjust macronutrient timing; increase fiber and plants; adjust fructose load.",
        "Lower inflammation",
        "Through nutrition, circadian alignment, and omega-3.",
        "Support mitochondrial function",
        "Maintain exercise, optimize micronutrients (magnesium, B-complex).",
        "Normalize Vitamin D",
        "Reduce dose.",
        "Improve evening metabolic activity",
        "Introduce low-intensity movement after 3–4 pm.",
        "Dermatologic follow-up",
        "Actinic keratosis & ulcerated lesion require evaluation.",
        "2.2. FUNCTIONAL MEDICINE APPROACH:",
        "MODIFIABLE LIFESTYLES AND DYSFUNCTIONS",
        "2.1. SUMMARY:",
        "2.3. VITAL SIGNS AND BODY COMPOSITION ANALYSIS (INBODY)"
      ]
    },
    "page_3": {
      "page_number": 3,
      "structured_content": [
        {
          "subheading": "PARAMETER"
        },
        {
          "subheading": "VALUE"
        },
        {
          "subheading": "INTERPRETATION/"
        },
        {
          "subheading": "OBSERVATION"
        },
        {
          "subheading": "BODY MASS"
        },
        {
          "subheading": "INDEX (BMI)",
          "content": [
            "31.1",
            "misleading in individuals with high",
            "muscle mass."
          ]
        },
        {
          "subheading": "BODY WEIGHT",
          "content": [
            "109.9 kg",
            "normal"
          ]
        },
        {
          "subheading": "HEIGHT",
          "content": [
            "1.88 m",
            "normal"
          ]
        },
        {
          "subheading": "ARTERIAL"
        },
        {
          "subheading": "PRESSURE",
          "content": [
            "145/83 mmHg",
            "STAGE II"
          ]
        },
        {
          "subheading": "CARDIAC"
        },
        {
          "subheading": "FREQUENCY",
          "content": [
            "51 bpm",
            "normal for an athlete man"
          ]
        },
        {
          "subheading": "ANKLE-BRACHIAL"
        },
        {
          "subheading": "INDEX",
          "content": [
            "non aplicable"
          ]
        },
        {
          "subheading": "ABDOMINAL"
        },
        {
          "subheading": "CIRCUMFERENCE",
          "content": [
            "102.8 cms",
            "out of range, normal less than 101"
          ]
        },
        {
          "subheading": "HIP WAIST"
        },
        {
          "subheading": "RATIO",
          "content": [
            "0.91",
            "slightly out of range, normal 0.90"
          ]
        },
        {
          "subheading": "PULSE"
        },
        {
          "subheading": "OXIMETRY",
          "content": [
            "96%",
            "normal"
          ]
        },
        {
          "subheading": "RESPIRATORY"
        },
        {
          "subheading": "FREQUENCY",
          "content": [
            "15 bpm",
            "normal"
          ]
        }
      ],
      "raw_lines": [
        "PARAMETER",
        "VALUE",
        "INTERPRETATION/",
        "OBSERVATION",
        "BODY MASS",
        "INDEX (BMI)",
        "31.1",
        "misleading in individuals with high ",
        "muscle mass.",
        "BODY WEIGHT",
        "109.9 kg",
        "normal ",
        "HEIGHT",
        "1.88 m",
        "normal ",
        "ARTERIAL",
        "PRESSURE",
        "145/83 mmHg",
        "STAGE II ",
        "CARDIAC",
        "FREQUENCY",
        "51 bpm ",
        "normal for an athlete man ",
        "ANKLE-BRACHIAL",
        "INDEX",
        "non aplicable ",
        "ABDOMINAL",
        "CIRCUMFERENCE",
        "102.8 cms ",
        "out of range, normal less than 101",
        "HIP WAIST",
        "RATIO",
        "0.91 ",
        "slightly out of range, normal 0.90",
        "PULSE",
        "OXIMETRY",
        "96%",
        "normal ",
        "RESPIRATORY",
        "FREQUENCY",
        "15 bpm",
        "normal"
      ]
    },
    "page_4": {
      "page_number": 4,
      "structured_content": [
        {
          "text": "The InBody analysis describes a 65-"
        },
        {
          "text": "year-old man, 188 cm tall and weighing"
        },
        {
          "text": "109.9 kg, with an exceptionally strong"
        },
        {
          "text": "and well-preserved body composition"
        },
        {
          "text": "for his age. His skeletal muscle mass is"
        },
        {
          "text": "49.7 kg, which is well above average"
        },
        {
          "text": "and places him in a category of"
        },
        {
          "text": "excellent muscularity. His fat-free mass"
        },
        {
          "text": "(87.3 kg) and total body water (64.1 L)"
        },
        {
          "text": "are also high, reflecting strong muscle"
        },
        {
          "text": "tissue quality. The whole-body"
        },
        {
          "text": "ECW/TBW ratio of 0.381 is normal,"
        },
        {
          "text": "indicating healthy fluid balance, and"
        },
        {
          "text": "the total phase angle of 6.5° is very"
        },
        {
          "text": "favorable for his age, showing good"
        },
        {
          "text": "cell integrity and metabolic function."
        },
        {
          "text": "His BMI is 31.1, which is technically in"
        },
        {
          "text": "the obesity range by definition, but this"
        },
        {
          "text": "classification does not apply well to"
        },
        {
          "text": "muscular individuals. The body fat"
        },
        {
          "text": "percentage of 20.6% is normal for a fit"
        },
        {
          "text": "adult male and especially good for a 65"
        },
        {
          "text": "-year-old, aligning with his high InBody"
        },
        {
          "text": "score of 94 out of 100, which confirms"
        },
        {
          "text": "excellent overall condition. The visceral"
        },
        {
          "text": "fat area is 106.4 cm², which sits near"
        },
        {
          "text": "the upper end of normal but not in a"
        },
        {
          "text": "dangerous or extreme range—"
        },
        {
          "text": "especially for a tall, muscular man."
        },
        {
          "text": "Many athletic or well-trained older"
        },
        {
          "text": "adults fall within this band. His waist"
        },
        {
          "text": "circumference (102.8 cm) and waist–"
        },
        {
          "text": "hip ratio (0.91) are slightly elevated,"
        },
        {
          "text": "but these values must be interpreted in"
        },
        {
          "text": "the context of his large frame and"
        },
        {
          "text": "muscle mass. Segmental analysis"
        },
        {
          "text": "shows strong, symmetrical muscle"
        },
        {
          "text": "across arms, legs, and trunk, with no"
        },
        {
          "text": "abnormalities. The metabolic rate"
        },
        {
          "text": "(2255 kcal) is high because of his"
        },
        {
          "text": "excellent muscle mass. Overall, the"
        },
        {
          "text": "report paints the picture of a very fit,"
        },
        {
          "text": "muscular, and healthy older adult with"
        },
        {
          "text": "excellent cellular integrity, strong"
        },
        {
          "text": "muscle mass, and only mild age-"
        },
        {
          "text": "related central fat accumulation, which"
        },
        {
          "text": "is extremely common. Nothing"
        },
        {
          "text": "indicates a pathological fat level, and"
        },
        {
          "text": "the high InBody score validates his"
        },
        {
          "text": "great physical condition."
        },
        {
          "subheading": "INBODY",
          "content": [
            "94/100"
          ]
        },
        {
          "subheading": "Additional parameters:"
        }
      ],
      "raw_lines": [
        "INBODY",
        "94/100",
        "The InBody analysis describes a 65-",
        "year-old man, 188 cm tall and weighing ",
        "109.9 kg, with an exceptionally strong ",
        "and well-preserved body composition ",
        "for his age. His skeletal muscle mass is ",
        "49.7 kg, which is well above average ",
        "and places him in a category of ",
        "excellent muscularity. His fat-free mass ",
        "(87.3 kg) and total body water (64.1 L) ",
        "are also high, reflecting strong muscle ",
        "tissue quality. The whole-body ",
        "ECW/TBW ratio of 0.381 is normal, ",
        "indicating healthy fluid balance, and ",
        "the total phase angle of 6.5° is very ",
        "favorable for his age, showing good ",
        "cell integrity and metabolic function. ",
        "His BMI is 31.1, which is technically in ",
        "the obesity range by definition, but this ",
        "classification does not apply well to ",
        "muscular individuals. The body fat ",
        "percentage of 20.6% is normal for a fit ",
        "adult male and especially good for a 65",
        "-year-old, aligning with his high InBody ",
        "score of 94 out of 100, which confirms ",
        "excellent overall condition. The visceral ",
        "fat area is 106.4 cm², which sits near ",
        "the upper end of normal but not in a ",
        "dangerous or extreme range—",
        "especially for a tall, muscular man. ",
        "Many athletic or well-trained older ",
        "adults fall within this band. His waist ",
        "circumference (102.8 cm) and waist–",
        "hip ratio (0.91) are slightly elevated, ",
        "but these values must be interpreted in ",
        "the context of his large frame and ",
        "muscle mass. Segmental analysis ",
        "shows strong, symmetrical muscle ",
        "across arms, legs, and trunk, with no ",
        "abnormalities. The metabolic rate ",
        "(2255 kcal) is high because of his ",
        "excellent muscle mass. Overall, the ",
        "report paints the picture of a very fit, ",
        "muscular, and healthy older adult with ",
        "excellent cellular integrity, strong ",
        "muscle mass, and only mild age-",
        "related central fat accumulation, which ",
        "is extremely common. Nothing ",
        "indicates a pathological fat level, and ",
        "the high InBody score validates his ",
        "great physical condition.",
        "Additional parameters:"
      ]
    },
    "page_5": {
      "page_number": 5,
      "structured_content": [
        {
          "subheading": "2.4. PHYSICAL EXAM:"
        },
        {
          "subheading": "ORGANS/SYSTEMS",
          "content": [
            "Regular rhythm, no audible murmurs.",
            "Lungs:",
            "Even breath sounds bilaterally, well ventilated."
          ]
        },
        {
          "subheading": "Cardiopulmonary"
        },
        {
          "subheading": "Neurological",
          "content": [
            "Alert and oriented; no neurological deficits."
          ]
        },
        {
          "subheading": "Head",
          "content": [
            "Normocephalic."
          ]
        },
        {
          "subheading": "Eyes",
          "content": [
            "Pupils equal, round, and reactive to light; extraocular movements intact."
          ]
        },
        {
          "subheading": "Neck",
          "content": [
            "Symmetrical, no palpable masses."
          ]
        },
        {
          "subheading": "Abdomen",
          "content": [
            "Soft and depressible; non-tender to palpation; no masses.",
            "Symmetrical; no signs of acute deep venous thrombosis; presence of",
            "venous insufficiency changes with ochre dermatitis in the left lower limb;",
            "distal pulses normal and symmetric; no pedal edema."
          ]
        },
        {
          "subheading": "Extremities",
          "content": [
            "Normal coloration, adequate turgor. On the right temporal region, there is a",
            "non-ulcerated actinic keratosis measuring approximately 1 × 1 cm.",
            "In the posterior crease of the left ear, there is a 5 mm ulcerated lesion."
          ]
        },
        {
          "subheading": "Skin"
        }
      ],
      "raw_lines": [
        "2.4. PHYSICAL EXAM:",
        "ORGANS/SYSTEMS",
        "Cardiopulmonary",
        "Regular rhythm, no audible murmurs.",
        "Lungs:",
        "Even breath sounds bilaterally, well ventilated.",
        "Neurological",
        "Alert and oriented; no neurological deficits.",
        "Head",
        "Normocephalic.",
        "Eyes",
        "Pupils equal, round, and reactive to light; extraocular movements intact.",
        "Neck",
        "Symmetrical, no palpable masses.",
        "Abdomen",
        "Soft and depressible; non-tender to palpation; no masses.",
        "Extremities",
        "Symmetrical; no signs of acute deep venous thrombosis; presence of ",
        "venous insufficiency changes with ochre dermatitis in the left lower limb; ",
        "distal pulses normal and symmetric; no pedal edema.",
        "Skin",
        "Normal coloration, adequate turgor. On the right temporal region, there is a ",
        "non-ulcerated actinic keratosis measuring approximately 1 × 1 cm.",
        "In the posterior crease of the left ear, there is a 5 mm ulcerated lesion."
      ]
    },
    "page_6": {
      "page_number": 6,
      "structured_content": [
        {
          "subheading": "2.5. LABORATORY RESULTS"
        },
        {
          "subheading": "Systems and Functions",
          "content": [
            "Hemoglobin17.0 g/dL14.3–17.0High-normal; consistent with prior history of",
            "polycythemia + morning dehydration + high muscle mass",
            "Hematocrit46.7%42–53Normal",
            "RBC count5.75 ×10⁶/µL3.7–5.5Slightly elevated → high-normal",
            "erythropoiesis pattern",
            "MCV81.2 fL80–95Normal",
            "MCH29.6 pg24–35Normal",
            "MCHC36.4 g/dL32–37Normal",
            "RDW-SD36.7 fL39–47Slightly low; not clinically relevant",
            "WBC6.98 ×10³/µL5–10Normal",
            "Neutrophils63.4% / 4.43 ×10³/µL35–70%Normal",
            "Lymphocytes26.6% / 1.86 ×10³/µL24–44%Normal",
            "Monocytes8.3%0–12%Normal",
            "Eosinophils1.0%0–5%Normal",
            "Basophils0.3%0–2%Normal",
            "Platelets153 ×10³/µL160–400Low-normal; stable",
            "Interpretation"
          ]
        },
        {
          "subheading": "Hematologic System",
          "content": [
            "Normal CBC overall, with a high-normal erythrocyte pattern consistent with",
            "his history (polycythemia), fitness level, and mild dehydration. No infection,",
            "inflammation, or hematologic disorder.",
            "hs-CRP1.5 mg/L<1.0 optimalMild metabolic inflammation → consistent with",
            "NAFLD"
          ]
        },
        {
          "subheading": "Inflammatory Markers",
          "content": [
            "Interpretation",
            "Slight inflammatory elevation, aligned with fatty liver disease (NAFLD",
            "grade II). No signs of acute inflammation.",
            "TSH2.40 uIU/mL0.40–4.00Normal thyroid function",
            "Testosterone total490.9 ng/dL127–1020Excellent level for age",
            "Vitamin D (25-OH)81.8 ng/mL30–74Elevated — excessive",
            "supplementation",
            "Fasting insulin14.4 µIU/mL2–17High-normal → mild insulin resistance",
            "(hepatic)",
            "Interpretation",
            "Normal thyroid and excellent testosterone level. Vitamin D is above optimal",
            "range. Insulin indicates early insulin resistance, compatible with NAFLD."
          ]
        },
        {
          "subheading": "Endocrine / Hormonal"
        },
        {
          "subheading": "System",
          "content": [
            "PSA",
            "0.80 ng/mL",
            "Excellent; very low prostate cancer risk"
          ]
        },
        {
          "subheading": "Tumor Markers",
          "content": [
            "Total cholesterol203 mg/dL0–200Mildly high",
            "HDL36 mg/dL40–65Low",
            "LDL140 mg/dL0–130Elevated (despite rosuvastatin)",
            "VLDL27 mg/dL5–40Normal",
            "Triglycerides133 mg/dL0–150Normal",
            "Castelli Index5.6<4.5 optimalElevated CV risk ratio",
            "ApoB112 mg/dL<80 optimalModerate — particle count normal range but",
            "not optimal",
            "Lp(a)1.9 mg/dL<30Excellent — genetically low cardiovascular risk",
            "Interpretation",
            "Mixed dyslipidemia driven by NAFLD, not by high cardiovascular risk.",
            "Lp(a) extremely low + calcium score = low actual risk."
          ]
        },
        {
          "subheading": "Cardiovascular / Lipid"
        },
        {
          "subheading": "System"
        }
      ],
      "raw_lines": [
        "2.5. LABORATORY RESULTS",
        "Systems and Functions",
        "Hematologic System",
        "Hemoglobin17.0 g/dL14.3–17.0High-normal; consistent with prior history of ",
        "polycythemia + morning dehydration + high muscle mass",
        "Hematocrit46.7%42–53Normal",
        "RBC count5.75 ×10⁶/µL3.7–5.5Slightly elevated → high-normal ",
        "erythropoiesis pattern",
        "MCV81.2 fL80–95Normal",
        "MCH29.6 pg24–35Normal",
        "MCHC36.4 g/dL32–37Normal",
        "RDW-SD36.7 fL39–47Slightly low; not clinically relevant",
        "WBC6.98 ×10³/µL5–10Normal",
        "Neutrophils63.4% / 4.43 ×10³/µL35–70%Normal",
        "Lymphocytes26.6% / 1.86 ×10³/µL24–44%Normal",
        "Monocytes8.3%0–12%Normal",
        "Eosinophils1.0%0–5%Normal",
        "Basophils0.3%0–2%Normal",
        "Platelets153 ×10³/µL160–400Low-normal; stable",
        "Interpretation",
        "Normal CBC overall, with a high-normal erythrocyte pattern consistent with ",
        "his history (polycythemia), fitness level, and mild dehydration. No infection, ",
        "inflammation, or hematologic disorder.",
        "Inflammatory Markers",
        "hs-CRP1.5 mg/L<1.0 optimalMild metabolic inflammation → consistent with ",
        "NAFLD",
        "Interpretation",
        "Slight inflammatory elevation, aligned with fatty liver disease (NAFLD ",
        "grade II). No signs of acute inflammation.",
        "Endocrine / Hormonal ",
        "System",
        "TSH2.40 uIU/mL0.40–4.00Normal thyroid function",
        "Testosterone total490.9 ng/dL127–1020Excellent level for age",
        "Vitamin D (25-OH)81.8 ng/mL30–74Elevated — excessive ",
        "supplementation",
        "Fasting insulin14.4 µIU/mL2–17High-normal → mild insulin resistance ",
        "(hepatic)",
        "Interpretation",
        "Normal thyroid and excellent testosterone level. Vitamin D is above optimal ",
        "range. Insulin indicates early insulin resistance, compatible with NAFLD.",
        "Tumor Markers",
        "PSA",
        "0.80 ng/mL",
        "Excellent; very low prostate cancer risk",
        "Cardiovascular / Lipid ",
        "System",
        "Total cholesterol203 mg/dL0–200Mildly high",
        "HDL36 mg/dL40–65Low",
        "LDL140 mg/dL0–130Elevated (despite rosuvastatin)",
        "VLDL27 mg/dL5–40Normal",
        "Triglycerides133 mg/dL0–150Normal",
        "Castelli Index5.6<4.5 optimalElevated CV risk ratio",
        "ApoB112 mg/dL<80 optimalModerate — particle count normal range but ",
        "not optimal",
        "Lp(a)1.9 mg/dL<30Excellent — genetically low cardiovascular risk",
        "Interpretation",
        "Mixed dyslipidemia driven by NAFLD, not by high cardiovascular risk.",
        "Lp(a) extremely low + calcium score = low actual risk."
      ]
    },
    "page_7": {
      "page_number": 7,
      "structured_content": [
        {
          "text": "TestResultReferenceInterpretation"
        },
        {
          "text": "AST56 U/L11–34Elevated"
        },
        {
          "text": "ALT54 U/L0–45Elevated"
        },
        {
          "text": "ALP74 U/L50–116Normal"
        },
        {
          "text": "GGT39 U/L0–55Normal"
        },
        {
          "text": "Interpretation"
        },
        {
          "text": "AST and ALT mildly elevated → hepatocellular injury pattern, consistent"
        },
        {
          "text": "with NAFLD grade II and possibly intense exercise. No cholestasis (normal"
        },
        {
          "text": "ALP + GGT)."
        },
        {
          "subheading": "Liver Function",
          "content": [
            "BUN19 mg/dLNormal",
            "Creatinine1.04 mg/dLNormal — excellent for high muscle mass",
            "eGFRNormalAppropriate for age"
          ]
        },
        {
          "subheading": "Renal Function",
          "content": [
            "Sodium139 mmol/L136–146Normal",
            "Potassium4.2 mmol/L3.5–5.1Normal",
            "Chloride106 mmol/L101–109Normal",
            "Calcium9.1 mg/dL8.8–10.2Normal",
            "Magnesium1.9 mg/dL1.8–2.6Normal-low",
            "Interpretation",
            "Electrolytes stable. Magnesium is low-normal — may benefit from",
            "supplementation."
          ]
        },
        {
          "subheading": "Electrolytes & Minerals",
          "content": [
            "Fasting glucose92 mg/dLNormal",
            "HbA1c5.1%Excellent",
            "Fasting insulin14.4High-normal",
            "Interpretation",
            "Glucose regulation excellent, but insulin suggests mild early insulin",
            "resistance → associated with NAFLD."
          ]
        },
        {
          "subheading": "Metabolic Panel"
        },
        {
          "subheading": "(Glucose Control)",
          "content": [
            "Clear, yellow urineNormal",
            "pH 5.0Slightly acidic (normal physiologic variant)",
            "No protein, glucose, blood, nitritesNo renal or urinary tract disease",
            "No WBCs or RBCsNo infection or hematuria",
            "Bacteria: “scant”Normal contamination",
            "Crystals, casts: noneNormal"
          ]
        },
        {
          "subheading": "Urinalysis",
          "content": [
            "No RBCsNo bleeding",
            "No WBCsNo inflammation",
            "No parasitesNormal",
            "Yeast: scantNormal microbiota",
            "Consistency: pastyNormal",
            "Color: brownNormal"
          ]
        },
        {
          "subheading": "Stool Examination"
        },
        {
          "subheading": "(Parasitology)"
        },
        {
          "subheading": "2.6. DIAGNOSTIC IMAGING AND ELECTROCARDIOGRAM"
        },
        {
          "subheading": "EKG:"
        }
      ],
      "raw_lines": [
        "Liver Function",
        "TestResultReferenceInterpretation",
        "AST56 U/L11–34Elevated",
        "ALT54 U/L0–45Elevated",
        "ALP74 U/L50–116Normal",
        "GGT39 U/L0–55Normal",
        "Interpretation",
        "AST and ALT mildly elevated → hepatocellular injury pattern, consistent ",
        "with NAFLD grade II and possibly intense exercise. No cholestasis (normal ",
        "ALP + GGT).",
        "Renal Function",
        "BUN19 mg/dLNormal",
        "Creatinine1.04 mg/dLNormal — excellent for high muscle mass",
        "eGFRNormalAppropriate for age",
        "Electrolytes & Minerals",
        "Sodium139 mmol/L136–146Normal",
        "Potassium4.2 mmol/L3.5–5.1Normal",
        "Chloride106 mmol/L101–109Normal",
        "Calcium9.1 mg/dL8.8–10.2Normal",
        "Magnesium1.9 mg/dL1.8–2.6Normal-low",
        "Interpretation",
        "Electrolytes stable. Magnesium is low-normal — may benefit from ",
        "supplementation.",
        "Metabolic Panel ",
        "(Glucose Control)",
        "Fasting glucose92 mg/dLNormal",
        "HbA1c5.1%Excellent",
        "Fasting insulin14.4High-normal",
        "Interpretation",
        "Glucose regulation excellent, but insulin suggests mild early insulin ",
        "resistance → associated with NAFLD.",
        "Urinalysis",
        "Clear, yellow urineNormal",
        "pH 5.0Slightly acidic (normal physiologic variant)",
        "No protein, glucose, blood, nitritesNo renal or urinary tract disease",
        "No WBCs or RBCsNo infection or hematuria",
        "Bacteria: “scant”Normal contamination",
        "Crystals, casts: noneNormal",
        "Stool Examination ",
        "(Parasitology)",
        "No RBCsNo bleeding",
        "No WBCsNo inflammation",
        "No parasitesNormal",
        "Yeast: scantNormal microbiota",
        "Consistency: pastyNormal",
        "Color: brownNormal",
        "2.6. DIAGNOSTIC IMAGING AND ELECTROCARDIOGRAM",
        "EKG:"
      ]
    },
    "page_8": {
      "page_number": 8,
      "structured_content": [
        {
          "text": "ECG Interpretation (Normal Study)"
        },
        {
          "text": "� Rhythm & Rate"
        },
        {
          "text": "Normal sinus rhythm, with upright P waves in leads I, II, and aVF."
        },
        {
          "text": "Rate appears within normal limits (~60–70 bpm)."
        },
        {
          "text": "Consistent P before every QRS and constant PR interval → normal AV conduction."
        },
        {
          "text": "� Intervals"
        },
        {
          "text": "PR interval: normal."
        },
        {
          "text": "QRS duration: narrow → no bundle branch block."
        },
        {
          "text": "QT interval: appears normal for heart rate."
        },
        {
          "text": "� Axis"
        },
        {
          "text": "Normal frontal plane axis; no deviation."
        },
        {
          "text": "� QRS Complex"
        },
        {
          "text": "No pathological Q waves."
        },
        {
          "text": "No signs of ventricular hypertrophy."
        },
        {
          "text": "Good R-wave progression across precordial leads (V1–V6)."
        },
        {
          "text": "� ST Segment & T Waves"
        },
        {
          "text": "ST segments are isoelectric, without elevation or depression → no evidence of ischemia or infarction."
        },
        {
          "text": "T waves are normal in morphology and distribution; no inversion or strain pattern."
        },
        {
          "text": "� Other Findings"
        },
        {
          "text": "No ectopy (no PACs, PVCs)."
        },
        {
          "text": "No signs of pericarditis, electrolyte imbalance, or arrhythmogenic patterns."
        },
        {
          "text": "Overall Impression"
        },
        {
          "text": "Normal ECG."
        },
        {
          "text": "No evidence of prior myocardial infarction, ischemia, arrhythmia, conduction abnormalities, or structural heart disease."
        },
        {
          "subheading": "Images:"
        }
      ],
      "raw_lines": [
        "ECG Interpretation (Normal Study)",
        "\u0000 Rhythm & Rate",
        "Normal sinus rhythm, with upright P waves in leads I, II, and aVF.",
        "Rate appears within normal limits (~60–70 bpm).",
        "Consistent P before every QRS and constant PR interval → normal AV conduction.",
        "\u0000 Intervals",
        "PR interval: normal.",
        "QRS duration: narrow → no bundle branch block.",
        "QT interval: appears normal for heart rate.",
        "\u0000 Axis",
        "Normal frontal plane axis; no deviation.",
        "\u0000 QRS Complex",
        "No pathological Q waves.",
        "No signs of ventricular hypertrophy.",
        "Good R-wave progression across precordial leads (V1–V6).",
        "\u0000 ST Segment & T Waves",
        "ST segments are isoelectric, without elevation or depression → no evidence of ischemia or infarction.",
        "T waves are normal in morphology and distribution; no inversion or strain pattern.",
        "\u0000 Other Findings",
        "No ectopy (no PACs, PVCs).",
        "No signs of pericarditis, electrolyte imbalance, or arrhythmogenic patterns.",
        "Overall Impression",
        "Normal ECG.",
        "No evidence of prior myocardial infarction, ischemia, arrhythmia, conduction abnormalities, or structural heart disease.",
        "Images:"
      ]
    },
    "page_9": {
      "page_number": 9,
      "structured_content": [
        {
          "text": "Abdominal ultrasound:"
        },
        {
          "text": "The abdominal ultrasound shows moderate hepatic steatosis (grade II) with a mildly enlarged and heterogeneous"
        },
        {
          "text": "liver, but no focal lesions, no signs of chronic liver disease, and no evidence of fibrosis or cirrhosis."
        },
        {
          "text": "The gallbladder is absent due to prior surgery, and the biliary ducts are normal."
        },
        {
          "text": "The pancreas shows moderate fatty infiltration (lipomatosis), a common age-related finding, with no masses or"
        },
        {
          "text": "inflammatory changes."
        },
        {
          "text": "The spleen and kidneys are normal, except for a small simple renal cyst (10 mm) on the right kidney, which is benign"
        },
        {
          "text": "and requires no intervention."
        },
        {
          "text": "The aorta, retroperitoneum, and urinary bladder are normal."
        },
        {
          "text": "The prostate is small and within normal size for his age (17.5 cc)."
        },
        {
          "text": "No free fluid, masses, or bowel abnormalities are seen."
        },
        {
          "text": "Impression"
        },
        {
          "text": "Moderate hepatic steatosis (grade II)."
        },
        {
          "text": "Moderate pancreatic lipomatosis."
        },
        {
          "text": "Benign simple renal cyst (right kidney)."
        },
        {
          "text": "Otherwise normal abdominal ultrasound."
        },
        {
          "text": "Coronary Calcium Score Summary"
        },
        {
          "text": "The patient’s total coronary artery calcium (CAC) score is 15, which places him in the 31st percentile according to"
        },
        {
          "text": "MESA (Multi-Ethnic Study of Atherosclerosis) reference values for individuals of the same age, sex, and ethnicity."
        },
        {
          "text": "Risk Interpretation"
        },
        {
          "text": "A CAC score of 15 corresponds to a low atherosclerotic burden and indicates a low risk of coronary artery disease."
        },
        {
          "text": "Most men his age have higher calcium levels, making this an overall favorable finding."
        },
        {
          "text": "Distribution of Calcium"
        },
        {
          "text": "Left Main (LM): 0"
        },
        {
          "text": "Left Anterior Descending (LAD): 7"
        },
        {
          "text": "Left Circumflex (LCx): 8"
        },
        {
          "text": "Right Coronary Artery (RCA): 0"
        },
        {
          "text": "Posterior Descending Artery (PDA): 0"
        },
        {
          "text": "Other branches: 0"
        },
        {
          "text": "Calcium is limited to small, isolated areas in the LAD and LCx, with no calcification in the Left Main or RCA—an"
        },
        {
          "text": "excellent prognostic sign."
        },
        {
          "text": "Clinical Implications"
        },
        {
          "text": "This score reflects low coronary plaque burden and reduced probability of obstructive coronary artery disease."
        },
        {
          "text": "Supports classification as low cardiovascular risk, especially when combined with his high fitness level and current"
        },
        {
          "text": "preventive medications (e.g., statin)."
        },
        {
          "text": "Ongoing risk factor management (blood pressure, lipid control, liver health, and lifestyle) remains appropriate."
        },
        {
          "text": "Follow-Up"
        },
        {
          "text": "According to current ACC/AHA guidelines, repeat CAC scoring is generally considered in 3–5 years, unless new"
        },
        {
          "text": "symptoms or risk factors emerge."
        },
        {
          "subheading": "Others:",
          "content": [
            "Non applicable"
          ]
        }
      ],
      "raw_lines": [
        "Non applicable ",
        "Abdominal ultrasound:",
        "The abdominal ultrasound shows moderate hepatic steatosis (grade II) with a mildly enlarged and heterogeneous ",
        "liver, but no focal lesions, no signs of chronic liver disease, and no evidence of fibrosis or cirrhosis.",
        "The gallbladder is absent due to prior surgery, and the biliary ducts are normal.",
        "The pancreas shows moderate fatty infiltration (lipomatosis), a common age-related finding, with no masses or ",
        "inflammatory changes.",
        "The spleen and kidneys are normal, except for a small simple renal cyst (10 mm) on the right kidney, which is benign ",
        "and requires no intervention.",
        "The aorta, retroperitoneum, and urinary bladder are normal.",
        "The prostate is small and within normal size for his age (17.5 cc).",
        "No free fluid, masses, or bowel abnormalities are seen.",
        "Impression",
        "Moderate hepatic steatosis (grade II).",
        "Moderate pancreatic lipomatosis.",
        "Benign simple renal cyst (right kidney).",
        "Otherwise normal abdominal ultrasound.",
        "Coronary Calcium Score Summary",
        "The patient’s total coronary artery calcium (CAC) score is 15, which places him in the 31st percentile according to ",
        "MESA (Multi-Ethnic Study of Atherosclerosis) reference values for individuals of the same age, sex, and ethnicity.",
        "Risk Interpretation",
        "A CAC score of 15 corresponds to a low atherosclerotic burden and indicates a low risk of coronary artery disease. ",
        "Most men his age have higher calcium levels, making this an overall favorable finding.",
        "Distribution of Calcium",
        "Left Main (LM): 0",
        "Left Anterior Descending (LAD): 7",
        "Left Circumflex (LCx): 8",
        "Right Coronary Artery (RCA): 0",
        "Posterior Descending Artery (PDA): 0",
        "Other branches: 0",
        "Calcium is limited to small, isolated areas in the LAD and LCx, with no calcification in the Left Main or RCA—an ",
        "excellent prognostic sign.",
        "Clinical Implications",
        "This score reflects low coronary plaque burden and reduced probability of obstructive coronary artery disease.",
        "Supports classification as low cardiovascular risk, especially when combined with his high fitness level and current ",
        "preventive medications (e.g., statin).",
        "Ongoing risk factor management (blood pressure, lipid control, liver health, and lifestyle) remains appropriate.",
        "Follow-Up",
        "According to current ACC/AHA guidelines, repeat CAC scoring is generally considered in 3–5 years, unless new ",
        "symptoms or risk factors emerge.",
        "Others:"
      ]
    },
    "page_10": {
      "page_number": 10,
      "structured_content": [
        {
          "subheading": "Section 3: Health Goals"
        },
        {
          "subheading": "Based on your personal goals, lifestyle, and health assessment,"
        },
        {
          "subheading": "we will set three key objectives that will allow us to"
        },
        {
          "subheading": "make significant progress toward your purpose."
        },
        {
          "subheading": "Goal #1:",
          "content": [
            "Reverse Fatty Liver (NAFLD Grade II)"
          ]
        },
        {
          "subheading": "KEY RESULTS"
        },
        {
          "subheading": "KEY ACTIONS"
        },
        {
          "subheading": "FREQUENCY",
          "content": [
            "Implement a liver-focused, anti-",
            "inflammatory diet:",
            "Reduce fructose (replace banana",
            "with ½ banana or berries).",
            "Increase vegetable intake to 6–7",
            "servings/day.",
            "Avoid refined sugars and processed",
            "foods.",
            "daily",
            "Add afternoon metabolic movement:",
            "10–15 minutes of light walking after",
            "lunch and dinner.",
            "Avoid prolonged sitting after 3 pm;",
            "move 3–5 minutes each hour.",
            "6 days a week"
          ]
        },
        {
          "subheading": "Improve liver health by reducing"
        },
        {
          "subheading": "inflammation and normalizing liver"
        },
        {
          "subheading": "enzymes.",
          "content": [
            "Support liver detoxification pathways",
            "with adequate hydration and",
            "phytonutrients:",
            "Drink 1.5–2.0 liters of water daily,",
            "especially in the morning to reduce",
            "hepatic congestion.",
            "Include daily liver-supportive foods",
            "such as cruciferous vegetables",
            "(broccoli, cauliflower, Brussels",
            "sprouts), leafy greens, garlic, onions,",
            "and fresh herbs (cilantro, parsley).",
            "These enhance phase I and phase II",
            "detoxification, reduce oxidative",
            "stress, and support hepatic fat",
            "clearance.",
            "daily"
          ]
        }
      ],
      "raw_lines": [
        "Section 3: Health Goals",
        "Based on your personal goals, lifestyle, and health assessment,",
        "we will set three key objectives that will allow us to",
        "make significant progress toward your purpose.",
        "Goal #1:",
        "Reverse Fatty Liver (NAFLD Grade II)",
        "KEY RESULTS",
        "KEY ACTIONS",
        "FREQUENCY",
        "Improve liver health by reducing ",
        "inflammation and normalizing liver ",
        "enzymes.",
        "Implement a liver-focused, anti-",
        "inflammatory diet:",
        "Reduce fructose (replace banana ",
        "with ½ banana or berries).",
        "Increase vegetable intake to 6–7 ",
        "servings/day.",
        "Avoid refined sugars and processed ",
        "foods.",
        "daily ",
        "Add afternoon metabolic movement:",
        "10–15 minutes of light walking after ",
        "lunch and dinner.",
        "Avoid prolonged sitting after 3 pm; ",
        "move 3–5 minutes each hour.",
        "6 days a week ",
        "Support liver detoxification pathways ",
        "with adequate hydration and ",
        "phytonutrients:",
        "Drink 1.5–2.0 liters of water daily, ",
        "especially in the morning to reduce ",
        "hepatic congestion.",
        "Include daily liver-supportive foods ",
        "such as cruciferous vegetables ",
        "(broccoli, cauliflower, Brussels ",
        "sprouts), leafy greens, garlic, onions, ",
        "and fresh herbs (cilantro, parsley).",
        "These enhance phase I and phase II ",
        "detoxification, reduce oxidative ",
        "stress, and support hepatic fat ",
        "clearance.",
        "daily"
      ]
    },
    "page_11": {
      "page_number": 11,
      "structured_content": [
        {
          "subheading": "Goal #2:",
          "content": [
            "Improve Insulin Sensitivity and Metabolic Flexibility"
          ]
        },
        {
          "subheading": "KEY RESULTS"
        },
        {
          "subheading": "KEY ACTIONS"
        },
        {
          "subheading": "FREQUENCY",
          "content": [
            "Adjust fasting and feeding schedule:",
            "Maintain morning fasting but add a",
            "small protein-based afternoon snack",
            "(Greek yogurt or nuts) to prevent",
            "hepatic overload.",
            "Ensure each meal contains protein +",
            "fiber.",
            "daily",
            "Increase daily fiber intake:",
            "1–2 teaspoons of psyllium or ground",
            "flaxseed daily.",
            "Supports glucose control and liver",
            "detoxification."
          ]
        },
        {
          "subheading": "Reduce hepatic insulin resistance"
        },
        {
          "subheading": "and improve metabolic efficiency.",
          "content": [
            "daily",
            "Add low-intensity cardio sessions:",
            "12–20 minutes of Zone 2–3 cardio",
            "(fast walking, cycling) 3 times per",
            "week.",
            "Complements his strength training",
            "routine.",
            "cardio 3 times a week"
          ]
        },
        {
          "subheading": "Goal #3:",
          "content": [
            "Optimize Cardiovascular Risk and Improve Lipid Profile"
          ]
        },
        {
          "subheading": "KEY RESULTS"
        },
        {
          "subheading": "KEY ACTIONS"
        },
        {
          "subheading": "FREQUENCY",
          "content": [
            "Improve fat quality and increase",
            "natural omega-3 intake:",
            "Eat fatty fish 2–3 times per week",
            "(salmon, sardines, tuna).",
            "Limit red meat to 1–2 times per",
            "week.",
            "as indicated"
          ]
        },
        {
          "subheading": "Improve lipid balance and reduce"
        },
        {
          "subheading": "long-term cardiovascular risk.",
          "content": [
            "Reduce Vitamin D supplementation:",
            "Lower dose to 2,000–3,000 IU/day.",
            "Goal serum level: 50–70 ng/mL.",
            "daily",
            "Mandatory post-meal walking:",
            "10–12 minutes of walking after the",
            "largest meal (usually lunch).",
            "Helps reduce postprandial lipids and",
            "improves HDL.",
            "6 times a week"
          ]
        },
        {
          "subheading": "- Progress happens through small steps. You're already on your way! -"
        }
      ],
      "raw_lines": [
        "Goal #2:",
        "Improve Insulin Sensitivity and Metabolic Flexibility",
        "KEY RESULTS",
        "KEY ACTIONS",
        "FREQUENCY",
        "Reduce hepatic insulin resistance ",
        "and improve metabolic efficiency.",
        "Adjust fasting and feeding schedule:",
        "Maintain morning fasting but add a ",
        "small protein-based afternoon snack ",
        "(Greek yogurt or nuts) to prevent ",
        "hepatic overload.",
        "Ensure each meal contains protein + ",
        "fiber.",
        "daily ",
        "Increase daily fiber intake:",
        "1–2 teaspoons of psyllium or ground ",
        "flaxseed daily.",
        "Supports glucose control and liver ",
        "detoxification.",
        "daily ",
        "Add low-intensity cardio sessions:",
        "12–20 minutes of Zone 2–3 cardio ",
        "(fast walking, cycling) 3 times per ",
        "week.",
        "Complements his strength training ",
        "routine.",
        "cardio 3 times a week ",
        "Goal #3:",
        "Optimize Cardiovascular Risk and Improve Lipid Profile",
        "KEY RESULTS",
        "KEY ACTIONS",
        "FREQUENCY",
        "Improve lipid balance and reduce ",
        "long-term cardiovascular risk.",
        "Improve fat quality and increase ",
        "natural omega-3 intake:",
        "Eat fatty fish 2–3 times per week ",
        "(salmon, sardines, tuna).",
        "Limit red meat to 1–2 times per ",
        "week.",
        "as indicated ",
        "Reduce Vitamin D supplementation:",
        "Lower dose to 2,000–3,000 IU/day.",
        "Goal serum level: 50–70 ng/mL.",
        "daily ",
        "Mandatory post-meal walking:",
        "10–12 minutes of walking after the ",
        "largest meal (usually lunch).",
        "Helps reduce postprandial lipids and ",
        "improves HDL.",
        "6 times a week ",
        "- Progress happens through small steps. You're already on your way! -"
      ]
    },
    "page_12": {
      "page_number": 12,
      "structured_content": [
        {
          "subheading": "Section 4: Action Plan"
        },
        {
          "subheading": "HOW WILL WE ACHIEVE SUCCESS?"
        },
        {
          "subheading": "At Sana Sana, we celebrate your commitment: we use health metrics to"
        },
        {
          "subheading": "guide the most effective steps, but we also understand that your well-being"
        },
        {
          "subheading": "goes far beyond the numbers. With your motivation and dedication, every"
        },
        {
          "subheading": "small achievement brings you closer to a longer, fuller life."
        },
        {
          "subheading": "Together, we will turn healthy habits into everyday victories!",
          "content": [
            "Improve Liver Health (Reverse NAFLD Grade II)"
          ]
        },
        {
          "subheading": "1."
        },
        {
          "subheading": "METRICS"
        },
        {
          "subheading": "HOW DO WE"
        },
        {
          "subheading": "MONITOR IT?"
        },
        {
          "subheading": "CURRENT"
        },
        {
          "subheading": "3-MONTH"
        },
        {
          "subheading": "GOAL"
        },
        {
          "subheading": "6-MONTH"
        },
        {
          "subheading": "GOAL",
          "content": [
            "ALT: 54 U/L  AST: 56",
            "U/L  Ferritin: 315",
            "ng/mL (previous)  hs-",
            "CRP: 1.5 mg/L",
            "Improve Liver Health",
            "(Reverse NAFLD",
            "Grade II)",
            "3 months <45 <45",
            "<250 <1.0",
            "6 months <40 <40",
            "<200 <0.8",
            "blood sample",
            "Improve Insulin Sensitivity (Reduce Hepatic IR)"
          ]
        },
        {
          "subheading": "2."
        },
        {
          "subheading": "METRICS"
        },
        {
          "subheading": "HOW DO WE"
        },
        {
          "subheading": "MONITOR IT?"
        },
        {
          "subheading": "CURRENT"
        },
        {
          "subheading": "3-MONTH"
        },
        {
          "subheading": "GOAL"
        },
        {
          "subheading": "6-MONTH"
        },
        {
          "subheading": "GOAL",
          "content": [
            "Fasting insulin: 14.4",
            "µIU/mL  Fasting",
            "glucose: 92 mg/dL",
            "Waist circumference:",
            "102.8 cm",
            "Fasting",
            "insulin: /Fasting",
            "glucose /Waist",
            "circumference",
            "blood sample and",
            "InBody",
            "3 months <12 88–92",
            "−2 cm",
            "6 months <10 85–90",
            "−4–5 cm",
            "Improve Lipid Profile / Cardiometabolic Risk"
          ]
        },
        {
          "subheading": "3."
        },
        {
          "subheading": "METRICS"
        },
        {
          "subheading": "HOW DO WE"
        },
        {
          "subheading": "MONITOR IT?"
        },
        {
          "subheading": "CURRENT"
        },
        {
          "subheading": "3-MONTH"
        },
        {
          "subheading": "GOAL"
        },
        {
          "subheading": "6-MONTH"
        },
        {
          "subheading": "GOAL",
          "content": [
            "LDL: 140 mg/dL  HDL:",
            "36 mg/dL  ApoB: 112",
            "mg/dL  Vitamin D: 81.8",
            "ng/mL",
            "reduce",
            "cardiometabolico risk",
            "blood sample",
            "3 months <125 >38",
            "<105 60–70",
            "6 months 100–120 >40",
            "<100 50–65"
          ]
        }
      ],
      "raw_lines": [
        "Section 4: Action Plan",
        "At Sana Sana, we celebrate your commitment: we use health metrics to",
        "guide the most effective steps, but we also understand that your well-being",
        "goes far beyond the numbers. With your motivation and dedication, every",
        "small achievement brings you closer to a longer, fuller life.",
        "Together, we will turn healthy habits into everyday victories!",
        "HOW WILL WE ACHIEVE SUCCESS?",
        "Improve Liver Health (Reverse NAFLD Grade II)",
        "1.",
        "METRICS",
        "HOW DO WE",
        "MONITOR IT?",
        "CURRENT",
        "3-MONTH",
        "GOAL",
        "6-MONTH",
        "GOAL",
        "Improve Liver Health ",
        "(Reverse NAFLD ",
        "Grade II)",
        "blood sample ",
        "ALT: 54 U/L  AST: 56 ",
        "U/L  Ferritin: 315 ",
        "ng/mL (previous)  hs-",
        "CRP: 1.5 mg/L",
        "3 months <45 <45 ",
        "<250 <1.0",
        "6 months <40 <40 ",
        "<200 <0.8",
        "Improve Insulin Sensitivity (Reduce Hepatic IR)",
        "2.",
        "METRICS",
        "HOW DO WE",
        "MONITOR IT?",
        "CURRENT",
        "3-MONTH",
        "GOAL",
        "6-MONTH",
        "GOAL",
        "Fasting ",
        "insulin: /Fasting ",
        "glucose /Waist ",
        "circumference",
        "blood sample and ",
        "InBody ",
        "Fasting insulin: 14.4 ",
        "µIU/mL  Fasting ",
        "glucose: 92 mg/dL  ",
        "Waist circumference: ",
        "102.8 cm",
        "3 months <12 88–92 ",
        "−2 cm",
        "6 months <10 85–90 ",
        "−4–5 cm",
        "Improve Lipid Profile / Cardiometabolic Risk",
        "3.",
        "METRICS",
        "HOW DO WE",
        "MONITOR IT?",
        "CURRENT",
        "3-MONTH",
        "GOAL",
        "6-MONTH",
        "GOAL",
        "reduce ",
        "cardiometabolico risk ",
        "blood sample ",
        "LDL: 140 mg/dL  HDL: ",
        "36 mg/dL  ApoB: 112 ",
        "mg/dL  Vitamin D: 81.8 ",
        "ng/mL",
        "3 months <125 >38 ",
        "<105 60–70",
        "6 months 100–120 >40 ",
        "<100 50–65"
      ]
    },
    "page_13": {
      "page_number": 13,
      "structured_content": [
        {
          "subheading": "Section 5: Complimentary Labs and Clinical References"
        },
        {
          "subheading": "Labs",
          "content": [
            "not neccesary at this time"
          ]
        },
        {
          "subheading": "References",
          "content": [
            "Dermathologist",
            "Peripheral vascular surgeon"
          ]
        },
        {
          "subheading": "Section 6: Follow-up and Frequency",
          "content": [
            "Recording your goals allows you to measure your effort,",
            "recognize your progress, and adjust your targets when necessary.",
            "We recommend tracking this habit using any of the following methods:",
            "Smart watch to track steps",
            "Interaction With Supplements",
            "Safe with rivaroxaban:",
            "Omega-3 (≤2 g/day) → mild increase in bleeding risk but still considered safe",
            "Vitamin D (decreasing dose is advised anyway)",
            "Psyllium, flaxseed",
            "Magnesium",
            "B-complex",
            "Use with caution:",
            "Turmeric/curcumin in high doses",
            "Ginger supplements",
            "High-dose fish oil (>2 g/day EPA/DHA)",
            "Vitamin E > 400 IU/day",
            "Avoid:",
            "Ginkgo biloba",
            "High-dose garlic supplements",
            "These can increase bleeding risk.",
            "vitamin D level (81.8 ng/mL) is above the optimal range. Although not dangerously high, levels above 70–80 ng/mL",
            "can increase the risk of:",
            "� Calcium buildup in the blood and kidneys",
            "High vitamin D can lead to hypercalcemia, which may cause kidney stones, vascular calcification, and increased",
            "urinary calcium.",
            "� Kidney strain",
            "Excess vitamin D increases calcium absorption, which the kidneys must filter, potentially stressing renal function over",
            "time.",
            "� No added benefit at high levels",
            "Studies show that vitamin D above 50–60 ng/mL does not provide extra immune or metabolic advantages. Higher",
            "levels only increase risk, not benefit.",
            "� Safer and more stable metabolism",
            "Keeping vitamin D in the optimal range (40–60 ng/mL) supports bone, immune, and metabolic health without",
            "increasing calcium-related risks.",
            "I recommend an omega-3 supplement that provides 1 gram of combined EPA and DHA per day, and not more than 2",
            "grams total.",
            "Nordic Naturals Ultimate Omega Soft Gels",
            "Sports Research Omega-3 Fish Oil (Triple Strength)",
            "Thorne Research Omega-3 (Con CoQ10)"
          ]
        }
      ],
      "raw_lines": [
        "Section 5: Complimentary Labs and Clinical References",
        "Labs",
        "not neccesary at this time",
        "References",
        "Dermathologist",
        "Peripheral vascular surgeon",
        "Section 6: Follow-up and Frequency",
        "Recording your goals allows you to measure your effort,",
        "recognize your progress, and adjust your targets when necessary.",
        "We recommend tracking this habit using any of the following methods:",
        "Smart watch to track steps",
        "Interaction With Supplements",
        "Safe with rivaroxaban:",
        "Omega-3 (≤2 g/day) → mild increase in bleeding risk but still considered safe",
        "Vitamin D (decreasing dose is advised anyway)",
        "Psyllium, flaxseed",
        "Magnesium",
        "B-complex",
        "Use with caution:",
        "Turmeric/curcumin in high doses",
        "Ginger supplements",
        "High-dose fish oil (>2 g/day EPA/DHA)",
        "Vitamin E > 400 IU/day",
        "Avoid:",
        "Ginkgo biloba",
        "High-dose garlic supplements",
        "These can increase bleeding risk.",
        "vitamin D level (81.8 ng/mL) is above the optimal range. Although not dangerously high, levels above 70–80 ng/mL ",
        "can increase the risk of:",
        "\u0000 Calcium buildup in the blood and kidneys",
        "High vitamin D can lead to hypercalcemia, which may cause kidney stones, vascular calcification, and increased ",
        "urinary calcium.",
        "\u0000 Kidney strain",
        "Excess vitamin D increases calcium absorption, which the kidneys must filter, potentially stressing renal function over ",
        "time.",
        "\u0000 No added benefit at high levels",
        "Studies show that vitamin D above 50–60 ng/mL does not provide extra immune or metabolic advantages. Higher ",
        "levels only increase risk, not benefit.",
        "\u0000 Safer and more stable metabolism",
        "Keeping vitamin D in the optimal range (40–60 ng/mL) supports bone, immune, and metabolic health without ",
        "increasing calcium-related risks.",
        "I recommend an omega-3 supplement that provides 1 gram of combined EPA and DHA per day, and not more than 2 ",
        "grams total.",
        "Nordic Naturals Ultimate Omega Soft Gels",
        "Sports Research Omega-3 Fish Oil (Triple Strength)",
        "Thorne Research Omega-3 (Con CoQ10)"
      ]
    },
    "page_14": {
      "page_number": 14,
      "structured_content": [
        {
          "text": "Based on your medical evaluation, we suggest that our next appointment be in"
        },
        {
          "text": "abdominal ultrasound in 6 months"
        },
        {
          "text": "labs in 3 months"
        },
        {
          "text": "If you have any questions or concerns about this guide, please don't hesitate to contact us."
        },
        {
          "subheading": "Whatsapp: 7262-7262"
        },
        {
          "subheading": "Medical Team Sana Sana: 8647-6931"
        },
        {
          "subheading": "We are here to support you on your journey toward better health."
        },
        {
          "subheading": "Report written by:"
        },
        {
          "subheading": "Dr.SILVIA ELENA GARITA PEÑA"
        },
        {
          "subheading": "Sana Sana Doctor"
        }
      ],
      "raw_lines": [
        "Based on your medical evaluation, we suggest that our next appointment be in",
        "abdominal ultrasound in 6 months",
        "labs in 3 months ",
        "If you have any questions or concerns about this guide, please don't hesitate to contact us.",
        "Whatsapp: 7262-7262",
        "Medical Team Sana Sana: 8647-6931",
        "We are here to support you on your journey toward better health.",
        "Report written by:",
        "Dr.SILVIA ELENA GARITA PEÑA",
        "Sana Sana Doctor"
      ]
    }
  }
}